JT
Jasper Therapeutics Inc
🇺🇸XNAS.JSPRUnited StatesHealthcare
$1.38USDup +0.04 (+2.99%)OpenDelayed2:23 PM
Price$1.38+0.04 (+2.99%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US4718712023
- CUSIP
- 471871103
Company
- Employees
- 22
- Headquarters
- Redwood City, United States
- Website
- https://jaspertx.com
- CEO
- Mr. Jeetinder Singh Mahal M.B.A.
Market
- Shares outstanding
- 33.3M
- Market cap
- $38.62M
Key dates
- Next earnings
- Nov 9, 2026
Highlights
- Market cap
- $38.62M
- EPS LTM
- -$1.11
- P/E LTM
- -0.02
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $0-100%down year on year
- Net income
- -$31.77M+65.06%up year on year
- Gross margin
- Not reported
- Free cash flow
- -$60.33M+18.31%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.